Experience of the Irish National Centre for hereditary haemorrhagic telangiectasia 2003-2008.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
Dept. of Radiology, National HHT Centre, Mercy University Hospital, Cork,, Ireland.Issue Date
2012-01-31T16:38:12ZMeSH
AdolescentAdult
Aged
Arteriovenous Malformations/*diagnosis/epidemiology/genetics
Child
Echocardiography
Female
Genotype
Humans
Ireland/epidemiology
Male
Middle Aged
Phenotype
Prevalence
Pulmonary Veins/*abnormalities
Telangiectasia, Hereditary Hemorrhagic/*diagnosis/epidemiology
Tomography, X-Ray Computed
Young Adult
Metadata
Show full item recordCitation
Respir Med. 2010 Aug;104(8):1218-24. Epub 2010 Apr 1.Journal
Respiratory medicineDOI
10.1016/j.rmed.2010.03.003PubMed ID
20362423Abstract
Hereditary haemorrhagic telangiectasia (HHT) is a group of autosomal dominant disorders of vascular structure. The Irish National Centre for HHT at the Mercy University Hospital, Cork, Ireland was founded in 2003. From 2003 to 2008, screening of 164 patients with contrast echocardiography, thoracic computerised tomography (CT) and cerebral magnetic resonance imaging (MRI) has identified 88 patients with definite HHT, 72 (82%) of whom had epistaxis, 70 (80%) had telangiectasia and 81 (92%) had a first-degree relative with HHT. We sought to describe the manifestations of HHT in an Irish population and to determine differences between internationally reported data. The HHT patient database was analysed to describe demographics, clinical manifestations and interventional procedures performed in all referred patients. Contrast echocardiography and/or CT were performed in 86 patients with definite HHT, identifying 27 patients (31%) with pulmonary arteriovenous malformations (pAVMs). Nineteen patients with single or multiple pAVMs had 28 embolisation procedures performed, with 1-6 pAVMs embolised per procedure. Cerebral MRI was performed in 78 (89%) patients and 2 (2.3%) had cerebral arteriovenous malformations (cAVMs). HHT prevalence is thought to be 1 in 2500-8000, suggesting that there are many undiagnosed cases in Irish patients. Internationally published data suggest a prevalence of 15-35% for pAVMs and 10-23% for cAVMs in patients with HHT. While the prevalence of pAVMs in our group is consistent with these data, the prevalence of cAVMs is considerably lower, suggesting that Irish patients with HHT may differ genotypically and phenotypically from those in other countries.Language
engISSN
1532-3064 (Electronic)0954-6111 (Linking)
ae974a485f413a2113503eed53cd6c53
10.1016/j.rmed.2010.03.003
Scopus Count
Collections
Related articles
- Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).
- Authors: Cottin V, Dupuis-Girod S, Lesca G, Cordier JF
- Issue date: 2007
- An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts.
- Authors: Marziniak M, Jung A, Guralnik V, Evers S, Prudlo J, Geisthoff UW
- Issue date: 2009 Jan
- Silent threat? A retrospective study of screening practices for pulmonary arteriovenous malformations in patients with hereditary haemorrhagic telangiectasia.
- Authors: Verkerk MM, Shovlin CL, Lund VJ
- Issue date: 2012 Sep
- Hereditary haemorrhagic telangiectasia: a cause of preventable morbidity and mortality.
- Authors: Brady AP, Murphy MM, O'Connor TM
- Issue date: 2009 Jun
- Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia.
- Authors: Al-Saleh S, Mei-Zahav M, Faughnan ME, MacLusky IB, Carpenter S, Letarte M, Ratjen F
- Issue date: 2009 Oct